LCZ696

Grade: Pharmaceutical Grade

Factory Location: shandong

Main Sales Markets: North America,Australasia,Asia,Middle East,Africa

Monthly Production Capacity: 5t

Contract Manufacturing: CRO,CMO

Packaging Information: 25kg/Cardboard bucket

Delivery Lead Time: 2-3Week

Sample Provided: yes

Payment Terms: DP/DA/TT/LC

LCZ696 is a drug developed by Novartis to treat heart failure, a life-threatening debilitating disease in which the heart cannot pump enough blood to supply the body, and symptoms such as dyspnea, fatigue and fluid retention can appear slowly and gradually worsen, significantly affecting quality of life.